Blue Trust’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
Blue Trust's TEVA Position: Q3 2026 in Review
Blue Trust increased its Teva Pharmaceutical Industries (TEVA) stake by 16% in Q3 2026, buying an estimated $12.2K and bringing the position to 2,427 shares worth $96.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1018.
Blue Trust first reported a position in TEVA in Q2 2022 and has held it in 18 quarters since. The position peaked at $238K in Q3 2024. 488 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.
- Blue Trust held 2,427 shares of Teva Pharmaceutical Industries worth $96.1K as of Q3 2026.
- Blue Trust bought 341 Teva Pharmaceutical Industries shares in Q3 2026, an estimated $12.2K.
- Teva Pharmaceutical Industries made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1018 holding.
- Blue Trust first reported a position in Teva Pharmaceutical Industries in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Teva Pharmaceutical Industries position peaked at $238K in Q3 2024.
- 488 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.